VIP Preclinical Development
SUTRO Biopharma
South San Francisco, California
Dr. Werner Rubas received his Pharmacist Degree and Ph. D. from ETH-Zürich, Switzerland and is currently VP of Pre-Clinical Development at SUTRO Biopharma in South SanFrancisco, CA.
Dr Rubas has spent over 30 years in the Biotech/Pharmaceutical Industry including Start-ups and Multinational Enterprises. During this time he worked on cardiovascular, chemokine antagonist, immuno-oncology, oncology, pain and virology projects. His experience includes liposomal delivery, small moelcules, protein therapeutics such as cytokines including PEGylated versions, monoclonal antobodies, antibody drug conjugates and growth factors. Prior to SUTRO Biopharma Dr. Rubas was the Executive Director for Non-Clinical PK/ADME at Nektar Therapeutics, San Francisco, CA. Werner has served as advisor to SPARK at Stanford University since 2010 providing PK/ADME advice to proncipal investigators and has been teaching a course on PK/ADME concepts at UC Berkley Extension for the past several years.
Dr. Rubas has advanced numereous assets through multi dimensional optimization leading to IND' filings for small molecules and protein therapeutics. He has contributed to NDA and BLA documents. He is a co-inventor on a patent application for an immonotherapeutic tumor treatment concept. He is the author or co-author on more than 40 peer reviewed publications and over 30 conference presentations.
Disclosure information not submitted.
Monday, October 17, 2022
9:30 AM – 10:00 AM ET